New Option for Sickle Cell Disease
The FDA has boosted treatment options for sickle cell disease by approving voxeletor for adults and adolescents aged 12 years or older who have the illness.
Source: JAMA - Category: General Medicine Source Type: research
More News: General Medicine | Sickle Cell Anemia